These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 23739956)
1. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. Harms AS; Cao S; Rowse AL; Thome AD; Li X; Mangieri LR; Cron RQ; Shacka JJ; Raman C; Standaert DG J Neurosci; 2013 Jun; 33(23):9592-600. PubMed ID: 23739956 [TBL] [Abstract][Full Text] [Related]
2. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
4. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease. Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878 [TBL] [Abstract][Full Text] [Related]
5. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873 [TBL] [Abstract][Full Text] [Related]
6. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease. Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204 [TBL] [Abstract][Full Text] [Related]
7. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Harms AS; Thome AD; Yan Z; Schonhoff AM; Williams GP; Li X; Liu Y; Qin H; Benveniste EN; Standaert DG Exp Neurol; 2018 Feb; 300():179-187. PubMed ID: 29155051 [TBL] [Abstract][Full Text] [Related]
9. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995 [TBL] [Abstract][Full Text] [Related]
10. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002 [TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. Theodore S; Cao S; McLean PJ; Standaert DG J Neuropathol Exp Neurol; 2008 Dec; 67(12):1149-58. PubMed ID: 19018246 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
13. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation. Zhang W; Gao JH; Yan ZF; Huang XY; Guo P; Sun L; Liu Z; Hu Y; Zuo LJ; Yu SY; Cao CJ; Wang XM; Hong JS Mol Neurobiol; 2018 Jan; 55(1):619-632. PubMed ID: 27975175 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Harms AS; Delic V; Thome AD; Bryant N; Liu Z; Chandra S; Jurkuvenaite A; West AB Acta Neuropathol Commun; 2017 Nov; 5(1):85. PubMed ID: 29162163 [TBL] [Abstract][Full Text] [Related]
15. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Thome AD; Standaert DG; Harms AS PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270 [TBL] [Abstract][Full Text] [Related]
16. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response. Wang M; Sun F; Han X; Wang N; Liu Y; Cai J; Tong S; Wang R; Wang H Mol Neurobiol; 2024 Jan; 61(1):252-265. PubMed ID: 37603153 [TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease. González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621 [TBL] [Abstract][Full Text] [Related]
19. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [TBL] [Abstract][Full Text] [Related]
20. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity. Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]